No description yet.
Durham, North Carolina, USA
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The source identifies the company in its coverage list as Precision Neuroscience; no investors, valuation, financing total, or headquarters are stated.
Held for review: earliest-report search pending
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series D | $250M | ~ 2026-09-29 | not stated | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source The source identifies the company in its coverage list as Precision Neuroscience; no investors, valuation, financing total, or headquarters are stated. Held for review: earliest-report search pending [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: bioworld.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source | ||||
None named.